LPTX News and Press, Leap Therapeutics Inc. From 09/13/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For anyone suffering from gastric or gastroesophageal junction cancer, a recent breakthrough from Leap Therapeutics (NASDAQ: LPTX ) has yielded seemingly promising results for a method of treatment. This morning, the ...

Gainers: Itamar Medical ITMR +45%, aTyr Pharma LIFE +35%, iRhythm Technologies (NASDAQ:IRTC) +33%, REGENXBIO RGNX +20%, Leap Therapeutics LPTX +15%. Losers: MiMedx MDXG -61%, Silverback Therapeutics (NASDAQ:SBTX) -24%, Dynavax T...

Itamar Medical (NASDAQ:ITMR) +44% on being taken over by Zoll Medical for ~$538M Leap Therapeutics (NASDAQ:LPTX) +42% to present new data from the DisTinGuish study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congres BELLUS Health (NASDAQ:BLU) +24% positive interim f...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! The weekend has come and gone and that means it’s time to get back into investing with a look at Monday’s biggest pre-market stock movers. Source: f11photo/Shutterstock.com We...

Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress - DKN-01 plus tislelizumab and chemotherapy demonstrated compelling activity in first-line patients with gastric or gastroesophageal junction cancer - In pa...

Are These Penny Stocks On Your List Right Now? In this article, we will take a look at 4 penny stocks with upcoming events very soon. How do we know this? One of the great things about certain industries is that companies will pre-announced key dates well in advance. Biotech companies a...

Leap Therapeutics to Participate at Two Upcoming Virtual Investor Conferences PR Newswire CAMBRIDGE, Mass. , Sept. 7, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology thera...

Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation PR Newswire CAMBRIDGE, Mass. , Aug. 13, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and imm...

EyeGate Pharmaceuticals EYEG +127% names Brian Strem CEO, proposes $7M Bayon dealObsEva SA OBSV +28%, Organon ink ebopiprant licensing deal for preterm laborOrbsat Corp. (OSAT) +27%.MOGU Inc. (MOGU) +21%  announces entry into Definitive Agreements to increase ownershi...

Leap Therapeutics to Present at the ESMO 2021 Virtual Congress PR Newswire CAMBRIDGE, Mass. , July 26, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today ...